118 related articles for article (PubMed ID: 15572529)
1. Lung cancer: clinical presentation and specialist referral time.
Buccheri G; Ferrigno D
Eur Respir J; 2004 Dec; 24(6):898-904. PubMed ID: 15572529
[TBL] [Abstract][Full Text] [Related]
2. Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis.
Corner J; Hopkinson J; Fitzsimmons D; Barclay S; Muers M
Thorax; 2005 Apr; 60(4):314-9. PubMed ID: 15790987
[TBL] [Abstract][Full Text] [Related]
3. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer.
Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR
Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279
[TBL] [Abstract][Full Text] [Related]
4. Time spans from first symptom to treatment in patients with lung cancer--the influence of symptoms and demographic characteristics.
Lövgren M; Leveälahti H; Tishelman C; Runesdotter S; Hamberg K
Acta Oncol; 2008; 47(3):397-405. PubMed ID: 17882556
[TBL] [Abstract][Full Text] [Related]
5. Delay between the initial symptoms, the diagnosis and the onset of specific treatment in elderly patients with lung cancer.
Giroux Leprieur E; Labrune S; Giraud V; Gendry T; Cobarzan D; Chinet T
Clin Lung Cancer; 2012 Sep; 13(5):363-8. PubMed ID: 22264658
[TBL] [Abstract][Full Text] [Related]
6. Delays in the diagnosis and treatment of lung cancer.
Salomaa ER; Sällinen S; Hiekkanen H; Liippo K
Chest; 2005 Oct; 128(4):2282-8. PubMed ID: 16236885
[TBL] [Abstract][Full Text] [Related]
7. The influence on survival of delay in the presentation and treatment of symptomatic breast cancer.
Richards MA; Smith P; Ramirez AJ; Fentiman IS; Rubens RD
Br J Cancer; 1999 Feb; 79(5-6):858-64. PubMed ID: 10070881
[TBL] [Abstract][Full Text] [Related]
8. Implications of a negative bronchoscopy on waiting times to treatment for lung cancer patients: results of a prospective tracking study.
Devbhandari MP; Quennell P; Krysiak P; Shah R; Jones MT
Eur J Cardiothorac Surg; 2008 Sep; 34(3):479-83. PubMed ID: 18667329
[TBL] [Abstract][Full Text] [Related]
9. Delay in diagnosis of lung cancer in general practice.
Bjerager M; Palshof T; Dahl R; Vedsted P; Olesen F
Br J Gen Pract; 2006 Nov; 56(532):863-8. PubMed ID: 17132354
[TBL] [Abstract][Full Text] [Related]
10. Under utilisation of the 2-week wait initiative for lung cancer by primary care and its effect on the urgent referral pathway.
Lewis NR; Le Jeune I; Baldwin DR
Br J Cancer; 2005 Oct; 93(8):905-8. PubMed ID: 16189521
[TBL] [Abstract][Full Text] [Related]
11. A prognostic model of recurrence and death in stage I non-small cell lung cancer utilizing presentation, histopathology, and oncoprotein expression.
Harpole DH; Herndon JE; Wolfe WG; Iglehart JD; Marks JR
Cancer Res; 1995 Jan; 55(1):51-6. PubMed ID: 7805040
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the use of a rapid diagnostic consultation of lung cancer. Delay time of diagnosis and therapy.
Hueto Pérez De Heredia J; Cebollero Rivas P; Cascante Rodrigo JA; Andrade Vela I; Pascal Martínez I; Boldú Mitjans J; Eguía Astibia VM
Arch Bronconeumol; 2012 Aug; 48(8):267-73. PubMed ID: 22575811
[TBL] [Abstract][Full Text] [Related]
13. Examining time intervals between diagnosis and treatment in the management of patients with limited stage small cell lung cancer.
Berthelet E; Truong PT; Lesperance M; Lim JT; Wai ES; MacNeil MV; Liu M; Joe H; Olivotto IA
Am J Clin Oncol; 2006 Feb; 29(1):21-6. PubMed ID: 16462498
[TBL] [Abstract][Full Text] [Related]
14. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
15. Referral-free health care and delay in diagnosis for lung cancer patients.
Hsieh VC; Wu TN; Liu SH; Shieh SH
Jpn J Clin Oncol; 2012 Oct; 42(10):934-9. PubMed ID: 22826351
[TBL] [Abstract][Full Text] [Related]
16. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
17. Is re-irradiation effective in symptomatic local recurrence of non small cell lung cancer patients? A single institution experience and review of the literature.
Cetingoz R; Arican-Alicikus Z; Nur-Demiral A; Durmak-Isman B; Bakis-Altas B; Kinay M
J BUON; 2009; 14(1):33-40. PubMed ID: 19373944
[TBL] [Abstract][Full Text] [Related]
18. Time course from first symptom to the treatment of lung cancer in the Eastern Black Sea Region of Turkey.
Ozlü T; Bülbül Y; Oztuna F; Can G
Med Princ Pract; 2004; 13(4):211-4. PubMed ID: 15181326
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of atypical metastasis from renal cell carcinoma (RCC).
Antonelli A; Arrighi N; Corti S; Legramanti S; Zanotelli T; Cozzoli A; Cunico SC; Simeone C
BJU Int; 2012 Dec; 110(11 Pt B):E559-63. PubMed ID: 22639956
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors.
Jacot W; Quantin X; Boher JM; Andre F; Moreau L; Gainet M; Depierre A; Quoix E; Chevalier TL; Pujol JL;
Br J Cancer; 2001 Apr; 84(7):903-9. PubMed ID: 11286469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
